Do you have high triglycerides, diabetes, and a history of heart attack or stroke?

Consider local research studies for heart health, enrolling now.

Those who qualify may receive*:

  • Payment varies by study up to $750
  • No-cost study-related care from a local doctor
  • No-cost study medication

Plus, no cost to you. No health insurance or referral needed.

Ready to get started? Click Here.

You may know your total cholesterol number, your “good” HDL cholesterol and your level of “bad” LDL cholesterol. But, may not know that triglycerides also play a role in heart disease and your risk for heart attack and stroke, and are often high if you are a diabetic.

Triglycerides are another type of fat that circulates in your bloodstream and are used by your body for energy. However, when your triglyceride levels become too high, you may be at higher risk for a heart attack or stroke.

Right now, local doctors are conducting research studies evaluating study medications for people with high triglycerides, diabetes and a history of heart attack or stroke, or other heart conditions. You may be eligible to participate!

Take the next step to see if you qualify for local research studies for people with high triglycerides, diabetes and a history of heart attack or stroke. But don’t delay — space is limited!

* In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.

Ready to get started?

Click Here.


Call 866-480-0682

How does it work?


Tell us a little bit about yourself


Answer some questions about your health


We will connect you to available studies in your area

Just takes a few minutes


AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.